Navigation Links
Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
Date:2/6/2008

echnologies' annual meeting of stockholders, as filed with the S.E.C. on a Schedule 14A. Information about the directors and executive officers of Tutogen and their ownership of Tutogen common stock is set forth in Tutogen's Annual Report on Form 10-K for the fiscal year ended September 30, 2007. Additional information regarding the interests of those participants and other persons who may be deemed participants in the merger may be obtained by reading the joint proxy statement/prospectus regarding the proposed merger filed with the S.E.C. on January 23, 2008. You may obtain free copies of these documents as described in the preceding paragraph.

Tutogen Medical, Inc.

Consolidated Statement of Income (Loss)

(In Thousands, Except for Share and Per Share Data)

Three Months Ended

December 31,

2007 2006

Revenue $ 14,955 $ 11,463

Cost of revenue 6,888 4,421

Gross profit 8,067 7,042

Operating Expenses

General and administrative 4,210 2,362

Distribution and marketing 4,553 3,441

Research and development 617 527

Total Operating Expenses 9,380 6,330

Operating (loss) income (1,313) 712

Foreign exchange loss (3) (38)

Interest and other income 130 34

Interest and other expense (86) (274)


'/>"/>

SOURCE Tutogen Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
3. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
4. Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results
5. Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results
6. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , February 26, 2015 ... subjects into PEACH, the first pivotal trial of ... dependent chronic kidney disease (DD-CKD), has completed as ... PT20, invented by leading UK-based scientists ... by Phosphate Therapeutics, is a novel phosphate binder ...
(Date:2/25/2015)... -- Today, BioMed Realty Trust, Inc. (NYSE: ... promotions and additions to its leadership team focused on ... returns through strategic investments in real estate at the ... innovation sector. The company also announced ... his role as President and Chief Operating Officer to ...
(Date:2/25/2015)... February 25, 2015 Salt ... $604,000 grant from the National Science Foundation’s ... (STEM) program. , The Foundation’s program supports scholarships ... enabling them to enter the workforce following completion ... STEM discipline. Institutions throughout the U.S. annually vie ...
(Date:2/25/2015)... February 25, 2015 FloDesign Sonics, Inc. ... Board of Directors. Michael “Mike” J. Harsh served as ... till Dec 2014, and led their Global Science and ... board will have a profound impact on our company. ... development of acoustic based products in life sciences. He ...
Breaking Biology Technology:Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 2BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 3BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 4SLCC Receives $600K National Science Foundation Grant 2FloDesign Sonics Inc adds Michael Harsh, Prior CTO GE Healthcare, to Board of Directors 2FloDesign Sonics Inc adds Michael Harsh, Prior CTO GE Healthcare, to Board of Directors 3
... Menards has selected a series of technology ... the company said Wednesday. , ,Menards deployed a ... Teradata Retail Logical Date Model. , ,Menards previously ... provide the information business users were demanding and often ...
... - The life sciences provider Promega broke ground on ... the Fitchburg Center, located next to the existing Promega offices. ... feet located near Cheryl Parkway and Fish Hatchery Road, 62,000 ... which will be retail space. The expansion will provide Promega ...
... Wis. -- The Medical College of Wisconsin has ... mechanisms by which inhaled anesthetics protect the human heart ... occurring during heart surgery. The college also has received ... injuries. , ,Zeljko Bosnjak, Ph.D., professor and vice chairman ...
Cached Biology Technology:
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
(Date:2/5/2015)... , 5. Februar 2015 ... spezialisiertes Logistikunternehmen und hat eine neue Marketingkampagne ... Logistikfirma (Clinical Logistics Organization – CLO) der ... Kampagne lautet First , mit Schwerpunkt ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 Logo ...
(Date:2/5/2015)... Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... ( http://www.nxt-id.com/ ) as part of its 2015 marketing ... Company launched its new consumer website for Wocketwallet.com earlier ... CEO of NXT-ID said, "Our new corporate website naturally ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... this webpage for pictures and videos! , ... as sea lilies look a lot like their garden-variety namesakes. ... sea lilies stayed rooted instead of moving around like their ... from a submersible research vessel at a depth of 430 ...
... to the Earth's landscape , The ice ages made massive ... the ice in the oceans? , Research by marine scientists ... whole communities of animals were wiped out by ice sheets ... been thought that these ecosystems somehow dodged extinction by recolonising ...
... The ice ages made massive changes to the Earth's landscape ... landscape. But what was happening below the ice in the ... a time of mass destruction as whole communities of animals ... , In the past it has been thought that these ...
Cached Biology News:Creeping crinoids! Sea lilies crawl to escape predators, new video shows 2Creeping crinoids! Sea lilies crawl to escape predators, new video shows 3Gene therapy may protect normal tissues during radiation retreatment for lung cancer 2Seafloor creatures destroyed by ice action during ice ages 2
Anti-LC3 Polyclonal Antibody Research Focus: cell surface antigens Storage: -20C Shipping Temperature: +4C...
Mouse monoclonal [SPM325] to Xanthine Oxidase, prediluted ( Abpromise for all tested applications). Antigen: C terminal 358 amino acid fragment of human xanthine oxidase. Entrez Gene ID: 749...
Rabbit polyclonal to Xanthine Oxidase (HRP) ( Abpromise for all tested applications). Antigen: Xanthine Oxidase (from Bovine Buttermilk) Entrez Gene ID: 7498 Swiss Protein ID: P47989...
... Disrupts biological cells for DNA isolation. ... well plates (includes 96 well plate ... lysis across the entire plate length ... Can be used for soil, ...
Biology Products: